Cargando…
Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds
BRAF inhibitors can delay the progression of metastatic melanoma, but resistance usually emerges, leading to relapse. Drugs simultaneously targeting two or more pathways essential for cancer growth could slow or prevent the development of resistant clones. Here, we identified pyridinyl imidazole com...
Autores principales: | Palušová, Veronika, Renzová, Tereza, Verlande, Amandine, Vaclová, Tereza, Medková, Michaela, Cetlová, Linda, Sedláčková, Miroslava, Hříbková, Hana, Slaninová, Iva, Krutá, Miriama, Rotrekl, Vladimír, Uhlířová, Hana, Křížová, Aneta, Chmelík, Radim, Veselý, Pavel, Krafčíková, Michaela, Trantírek, Lukáš, Schink, Kay Oliver, Uldrijan, Stjepan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352453/ https://www.ncbi.nlm.nih.gov/pubmed/32531927 http://dx.doi.org/10.3390/cancers12061516 |
Ejemplares similares
-
CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells
por: Štětková, Monika, et al.
Publicado: (2020) -
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480
por: Gudernova, Iva, et al.
Publicado: (2017) -
A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
por: Kosztyu, Pavlína, et al.
Publicado: (2019) -
Notch stimulates growth by direct regulation of genes involved in the control of glycolysis and the tricarboxylic acid cycle
por: Slaninova, Vera, et al.
Publicado: (2016) -
Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels independent of its deubiquitinase activity
por: Cetkovská, Kateřina, et al.
Publicado: (2017)